Trial · NCT00071032
Results by group38
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 38
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Inability to Walk 10 Feet or Across a Room Without Human Assistance or Death | Liberal (10 g/dL) Transfusion Strategy | 351 | participants | ||
| Inability to Walk 10 Feet or Across a Room Without Human Assistance or Death | Restrictive Strategy | 347 | participants | ||
| Myocardial Infarction, Unstable Angina, or Death for Any Reason | Liberal (10 g/dL) Transfusion Strategy | 43 | participants | ||
| Myocardial Infarction, Unstable Angina, or Death for Any Reason | Restrictive Strategy | 52 | participants | ||
| Mortality at 30 Days | Liberal (10 g/dL) Transfusion Strategy | 52 | Participants | ||
| Mortality at 30 Days | Restrictive Strategy | 43 | Participants | ||
| Mortality at 60 Days | Liberal (10 g/dL) Transfusion Strategy | 76 | Participants | ||
| Mortality at 60 Days | Restrictive Strategy | 66 | Participants | ||
| Composite Outcomes (a) Death, Myocardial Infarction, or Pneumonia and b) Death, Myocardial Infarction, Pneumonia, Thromboembolism, or Stroke | Liberal (10 g/dL) Transfusion Strategy | Death, myocardial infarction, or pneumonia | 89 | Participants | |
| Composite Outcomes (a) Death, Myocardial Infarction, or Pneumonia and b) Death, Myocardial Infarction, Pneumonia, Thromboembolism, or Stroke | Restrictive Strategy | Death, myocardial infarction, or pneumonia | 90 | Participants | |
| Composite Outcomes (a) Death, Myocardial Infarction, or Pneumonia and b) Death, Myocardial Infarction, Pneumonia, Thromboembolism, or Stroke | Liberal (10 g/dL) Transfusion Strategy | Death, MI, pnuemonia, thromboembolism or stroke | 103 | Participants | |
| Composite Outcomes (a) Death, Myocardial Infarction, or Pneumonia and b) Death, Myocardial Infarction, Pneumonia, Thromboembolism, or Stroke | Restrictive Strategy | Death, MI, pnuemonia, thromboembolism or stroke | 94 | Participants | |
| Myocardial Infarction | Liberal (10 g/dL) Transfusion Strategy | 23 | Participants | ||
| Myocardial Infarction | Restrictive Strategy | 38 | Participants | ||
| Postoperative Complications (e.g., Wound Infection, Thromboembolism, Stroke) | Liberal (10 g/dL) Transfusion Strategy | Wound Infection | 14 | Participants | |
| Postoperative Complications (e.g., Wound Infection, Thromboembolism, Stroke) | Restrictive Strategy | Wound Infection | 8 | Participants | |
| Postoperative Complications (e.g., Wound Infection, Thromboembolism, Stroke) | Liberal (10 g/dL) Transfusion Strategy | Thromboembolism | 12 | Participants | |
| Postoperative Complications (e.g., Wound Infection, Thromboembolism, Stroke) | Restrictive Strategy | Thromboembolism | 8 | Participants | |
| Postoperative Complications (e.g., Wound Infection, Thromboembolism, Stroke) | Liberal (10 g/dL) Transfusion Strategy | Stroke | 8 | Participants | |
| Postoperative Complications (e.g., Wound Infection, Thromboembolism, Stroke) | Restrictive Strategy | Stroke | 3 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00071032/results